![]() |
Xin (Sheen) Xu
Mr. Xu is an associate in Davis Polk’s Corporate Department, currently practicing as a Registered Foreign Lawyer in Hong Kong. Since joining the firm in 2017, he has completed a rotation in the Mergers and Acquisitions Group. |
Work Highlights
Capital Markets
- Adagene Inc.’s $161 million US IPO
- Provident Acquisition Corp.’s $230 million IPO on Nasdaq
- Zai Lab's $766 million Hong Kong secondary listing
- Genetron Holdings Limited’s $256 million US IPO
- InflaRx N.V.’s $100 million US IPO
- CNFinance’s $51.9 million US IPO
- Ingersoll-Rand Global’s $1.15 billion SEC-registered senior notes offering
- Westlake Chemical Corporation’s $500 million SEC-registered notes offering
- iQIYI’s $750 million debut Rule 144A and Reg S convertible notes offering
- Universal American’s $115 million Rule 144A convertible notes offering
- China Orient Asset Management’s $8 billion MTN program update and upsizing and $2 billion investment-grade bonds offering and $700 million investment-grade bonds offering
- 21Vianet Group, Inc.’s $300 million high-yield notes offering and concurrent cash tender offer
- China Oil and Gas Group Limited $320 million high-yield notes offering
- KWG Group Holdings’ $300 million and $350 million high-yield notes offerings
M&A
-
Tencent and Tencent Music Entertainment’s strategic investment in Universal Music Group
-
Emerson’s acquisition of General Electric’s Intelligent Platforms business
-
A.P. Møller – Maersk on forming a broad strategic relationship with IBM
Of Note
Article
- “Note: Show Me the Money: Evaluating Personal Jurisdiction over Foreign Nonparty Banks in Light of the Gucci Case,” 49 Cornell Int’l L.J.745 (2016)
Professional History
- Davis Polk since 2017
- Hong Kong office, 2018 – Present
- New York office, 2017 – 2018
-
Judicial Intern, Hon. Elizabeth A. Wolford, U.S. District Court, WDNY, 2015